Holen Sie sich die Stockscreener-App
20.57
0.63%
-0.13
Handel nachbörslich:
20.50
-0.07
-0.34%
Finanzdaten der Denali Therapeutics Inc-Aktie (DNLI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
0.05%
137.37
|
137.43 | 134.96 | 145.58 | 123.19 |
| Operating Income/Loss |
0.05%
-137.37
|
-137.43 | -134.96 | -145.58 | -123.19 |
| Income/Loss From Continuing Operations Before Tax |
1.22%
-128.45
|
-126.90 | -124.12 | -132.97 | -107.19 |
| Income/Loss From Continuing Operations After Tax |
1.30%
-128.55
|
-126.90 | -124.12 | -132.97 | -107.19 |
|
Net Income/Loss
|
1.30%
-128.55
|
-126.90 | -124.12 | -132.97 | -107.19 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.45%
0.9469
|
172.42 | 171.45 | 171.22 | 169.46 |
| Diluted Average Shares |
99.45%
0.9469
|
172.42 | 171.45 | 171.22 | 169.46 |
| Basic Earnings Per Share |
1.35%
-0.73
|
-0.74 | -0.72 | -0.78 | -0.63 |
| Diluted Earnings Per Share |
1.35%
-0.73
|
-0.74 | -0.72 | -0.78 | -0.63 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):